BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6847896)

  • 1. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model.
    Varsos VG; Liszczak TM; Han DH; Kistler JP; Vielma J; Black PM; Heros RC; Zervas NT
    J Neurosurg; 1983 Jan; 58(1):11-7. PubMed ID: 6847896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall.
    Liszczak TM; Varsos VG; Black PM; Kistler JP; Zervas NT
    J Neurosurg; 1983 Jan; 58(1):18-26. PubMed ID: 6847905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage.
    Tsukahara T; Yoshimura S; Kazekawa K; Hashimoto N
    J Auton Nerv Syst; 1994 Sep; 49 Suppl():S163-6. PubMed ID: 7836675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm.
    Gioia AE; White RP; Bakhtian B; Robertson JT
    J Neurosurg; 1985 May; 62(5):721-8. PubMed ID: 3838768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on the effects of intrathecal papaverine in experimental vasospasm.
    Ogata M; Marshall BM; Lougheed WM
    J Neurosurg; 1973 Jan; 38(1):20-5. PubMed ID: 4629882
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of vasodilation by milrinone, a phosphodiesterase III inhibitor, on vasospastic arteries after a subarachnoid hemorrhage in vitro and in vivo: effectiveness of cisternal injection of milrinone.
    Nishiguchi M; Ono S; Iseda K; Manabe H; Hishikawa T; Date I
    Neurosurgery; 2010 Jan; 66(1):158-64; discussion 164. PubMed ID: 20023546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cerebral vasospasm by control of cyclic adenosine monophosphate.
    Flamm ES; Ransohoff J
    Surg Neurol; 1976 Oct; 6(4):223-6. PubMed ID: 184555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental cerebral vasospasm. Part 2: effects of vasoactive drugs and sympathectomy on early and late spasm.
    Nagai H; Noda S; Mabe H
    J Neurosurg; 1975 Apr; 42(4):420-8. PubMed ID: 1123659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experiment delayed cerebral arterial spasm with a beta2-adrenergic stimulator and a phosphodiesterase inhibitor.
    Norwood CW; Poole J; Moody D
    J Neurosurg; 1976 Nov; 45(5):491-7. PubMed ID: 823307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic cerebral vasospasm: effect of calcium antagonists.
    Zabramski J; Spetzler RF; Bonstelle C
    Neurosurgery; 1986 Feb; 18(2):129-35. PubMed ID: 3960287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral aterial spasm. I. Adrenergic mechanism in experimental cerebral vasospasm.
    Morooka H
    Acta Med Okayama; 1978 Apr; 32(1):23-37. PubMed ID: 148833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of in vivo angioplasty in normal and vasospastic canine carotid arteries: pharmacological and morphological analyses.
    Megyesi JF; Vollrath B; Cook DA; Chen MH; Findlay JM
    J Neurosurg; 1999 Jul; 91(1):100-8. PubMed ID: 10389887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of intracisternal papaverine on symptomatic vasospasm].
    Segawa H; Saito I; Okada T; Nagayama I; Kitamura K; Takakura K; Sano K
    No Shinkei Geka; 1986 Jun; 14(7):847-54. PubMed ID: 3762853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition.
    Gavras H; Andrews P; Papadakis N
    J Neurosurg; 1981 Dec; 55(6):884-8. PubMed ID: 6170740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subarachnoid hemorrhage and cerebrovascular spasm. Morphological study of intracranial arteries based on animal experiments and human autopsies.
    Eldevik OP; Kristiansen K; Torvik A
    J Neurosurg; 1981 Dec; 55(6):869-76. PubMed ID: 7299462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage.
    Seifert V; Eisert WG; Stolke D; Goetz C
    Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminophylline and isoproterenol in the treatment of cerebral vasopasm.
    Fleischer AS; Raggio JF; Tindall GT
    Surg Neurol; 1977 Aug; 8(2):117-21. PubMed ID: 888087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained release of papaverine for the treatment of cerebral vasospasm: in vitro evaluation of release kinetics and biological activity.
    Heffez DS; Leong KW
    J Neurosurg; 1992 Nov; 77(5):783-7. PubMed ID: 1403123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxant effect of calcitonin gene-related peptide on cerebral arterial spasm induced by experimental subarachnoid hemorrhage in dogs.
    Nozaki K; Uemura Y; Okamoto S; Kikuchi H; Mizuno N
    J Neurosurg; 1989 Oct; 71(4):558-64. PubMed ID: 2795174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 5-lipoxygenase inhibitor on experimental delayed cerebral vasospasm.
    Yokota M; Tani E; Maeda Y; Kokubu K
    Stroke; 1987; 18(2):512-8. PubMed ID: 3564111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.